QUCY
Mainz Biomed N.V.
NASDAQ: QUCY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.43
-6.65% today
Updated 2026-04-30
Market cap
$6.28M
P/E ratio
—
P/S ratio
11.69x
EPS (TTM)
$-2.70
Dividend yield
—
52W range
$0 – $1
Volume
0.8M
Mainz Biomed N.V. (QUCY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-3.22M | $-14.77M | $-21.94M | $-17.09M | $-10.98M |
| Capital expenditures | $16705.00 | $658483.00 | $1.90M | $254949.00 | $1.05M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $6.43M | $9.82M | $4.01M | $1.14M | $2.68M |
| Free cash flow | $-3.24M | $-15.43M | $-23.84M | $-17.34M | $-12.03M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |